Skip to content
HealthTech Series A Founded 2020

Broken String Biosciences

Broken String Biosciences develops biopharmaceutical products and cell therapies using genome sequencing data, having developed INDUCE-seq technology for measuring DNA breaks throughout the genome. This technology determines the mechanism of double-strand break repair, facilitating the development of therapeutic genome editing for cancer, immunological health, and other diseases. Founded in 2020 and headquartered in…

📍 Cambridge, United Kingdom · Life Sciences Tech,

Funding snapshot

Last roundSeries A
Amount$15M
Date18 September 2023
Total raised$15M
Team size37

About

Broken String Biosciences develops biopharmaceutical products and cell therapies using genome sequencing data, having developed INDUCE-seq technology for measuring DNA breaks throughout the genome. This technology determines the mechanism of double-strand break repair, facilitating the development of therapeutic genome editing for cancer, immunological health, and other diseases. Founded in 2020 and headquartered in Cambridge, United Kingdom, Broken String Biosciences has raised approximately $15M in Series A funding from investors including Illumina, Illumina Ventures, Merieux Equity Partners, Tencent, Dieter von Holtzbrinck Ventures, and HERAN Partners. The company's sequencing technology enables precise characterization of off-target effects in gene editing, addressing a critical safety requirement for the development of CRISPR-based therapeutics by providing comprehensive genome-wide assessment of DNA damage patterns caused by gene editing tools.

Business model

Life Sciences Tech > Research & Development > Drug Discovery > Genomics > Sequencing Analysis,

Genomics > Genome Informatics > Sequence Analysis

Institutional investors

Dieter von Holtzbrinck Ventures Illumina Illumina Ventures Merieux Equity Partners HERAN Partners Tencent First In Ventures Korys Digital Health Ventures Universitycollegecardiffconsultants Image Frame Investment Cambridgeshire and Peterborough Combined Authority Time Partners David Wallerstein Kyle Kurpinski

Latest coverage

No articles yet.

Raising like Broken String Biosciences?

Analyze your pitch deck before your next raise.

Analyze My Deck →